Drugs / Nascum Plus
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT03772405 | Dec 2018 → Feb 2019 | seasonal allergic rhinitis | Fraunhofer-Institute of Toxicology and Experimental Medicine | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Nascum-Plus | “The aim of this study is to assess if a physical barrier, created by the nasal gel Nascum®- Plus, is able to prevent or minimize the induction of nasal symptoms during allergen...” NCT03772405 ↗ |
| Route | Intranasal | “nasal application of nascum plus” NCT03772405 ↗ |